Overview
- A peer‑reviewed preclinical paper in Nature Aging published in late July 2026 reports that molecules secreted by ovarian cancer cells that survive chemotherapy include fructose, and those molecules alone increase tumor spread in lab and animal models.
- Large‑scale analyses and a CRISPR screen in the study show fructose suppresses cholesterol synthesis in neighbouring tumor cells, which reduces membrane “stickiness” and lets cells detach more easily to form metastases.
- The team found that a high‑fructose diet produced similar increases in metastasis in mouse models, suggesting dietary sources such as sugary drinks could mimic the same signalling in preclinical systems.
- The authors note there is no clinical evidence yet and explicitly advise patients not to stop statins or change medications based on these results, while also raising questions about possible interactions between cholesterol‑lowering drugs and chemotherapy.
- Researchers at The Wistar Institute have begun reproducibility experiments and plan to test whether the fructose‑driven mechanism applies to other torso‑spreading cancers, and they call for human studies to determine patient‑level effects.